메뉴 건너뛰기




Volumn 8, Issue 11, 2013, Pages

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRCA2 GENE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; DISEASE ASSOCIATION; DNA REPAIR; EXOME; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE;

EID: 84893049346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080023     Document Type: Article
Times cited : (123)

References (29)
  • 1
    • 80053426842 scopus 로고    scopus 로고
    • Targeted therapies for breast cancer
    • doi:10.1172/JCI57152. PubMed: 21965336
    • Higgins MJ, Baselga J (2011) Targeted therapies for breast cancer. J Clin Invest 121: 3797-3803. doi:10.1172/JCI57152. PubMed: 21965336.
    • (2011) J Clin Invest , vol.121 , pp. 3797-3803
    • Higgins, M.J.1    Baselga, J.2
  • 2
    • 77950633401 scopus 로고    scopus 로고
    • New strategies in estrogen receptor-positive breast cancer
    • doi: 10.1158/1078-0432.CCR-09-1823. PubMed: 20332324
    • Johnston SR (2010) New strategies in estrogen receptor-positive breast cancer. Clin Cancer Res 16: 1979-1987. doi: 10.1158/1078-0432.CCR-09-1823. PubMed: 20332324.
    • (2010) Clin Cancer Res , vol.16 , pp. 1979-1987
    • Johnston, S.R.1
  • 3
    • 0037169354 scopus 로고    scopus 로고
    • Cancer susceptibility and the functions of BRCA1 and BRCA2
    • doi:10.1016/S0092-8674(02)00615-3. PubMed: 11832208
    • Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182. doi:10.1016/S0092-8674(02)00615-3. PubMed: 11832208.
    • (2002) Cell , vol.108 , pp. 171-182
    • Venkitaraman, A.R.1
  • 4
    • 32044453343 scopus 로고    scopus 로고
    • X chromosomal abnormalities in basal-like human breast cancer
    • doi:10.1016/j.ccr.2006.01.013. PubMed: 16473279
    • Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M et al. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9: 121-132. doi:10.1016/j.ccr.2006.01.013. PubMed: 16473279.
    • (2006) Cancer Cell , vol.9 , pp. 121-132
    • Richardson, A.L.1    Wang, Z.C.2    De Nicolo, A.3    Lu, X.4    Brown, M.5
  • 5
    • 59449098395 scopus 로고    scopus 로고
    • Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas
    • doi:10.1158/1078-0432.CCR-08-1291. PubMed: 19047089
    • Walsh CS, Ogawa S, Scoles DR, Miller CW, Kawamata N et al. (2008) Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas. Clin Cancer Res 14: 7645-7651. doi:10.1158/1078-0432.CCR-08- 1291. PubMed: 19047089.
    • (2008) Clin Cancer Res , vol.14 , pp. 7645-7651
    • Walsh, C.S.1    Ogawa, S.2    Scoles, D.R.3    Miller, C.W.4    Kawamata, N.5
  • 6
    • 84856158117 scopus 로고    scopus 로고
    • Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer
    • doi:10.1001/jama.2012.20. PubMed: 22274685
    • Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ et al. (2012) Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA 307: 382-390. doi:10.1001/jama.2012.20. PubMed: 22274685.
    • (2012) JAMA , vol.307 , pp. 382-390
    • Bolton, K.L.1    Chenevix-Trench, G.2    Goh, C.3    Sadetzki, S.4    Ramus, S.J.5
  • 7
    • 17244373777 scopus 로고    scopus 로고
    • Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
    • doi:10.1038/nature03445. PubMed: 15829967
    • Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921. doi:10.1038/nature03445. PubMed: 15829967.
    • (2005) Nature , vol.434 , pp. 917-921
    • Farmer, H.1    McCabe, N.2    Lord, C.J.3    Tutt, A.N.4    Johnson, D.A.5
  • 8
    • 84864026311 scopus 로고    scopus 로고
    • BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian Ovarian Cancer Study Group
    • doi:10.1200/JCO.2011.39.8545. PubMed: 22711857
    • Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C et al. (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 30: 2654-2663. doi:10.1200/JCO.2011.39.8545. PubMed: 22711857.
    • (2012) J Clin Oncol , vol.30 , pp. 2654-2663
    • Alsop, K.1    Fereday, S.2    Meldrum, C.3    DeFazio, A.4    Emmanuel, C.5
  • 9
    • 79959838081 scopus 로고    scopus 로고
    • Integrated genomic analyses of ovarian carcinoma
    • doi:10.1038/nature10166. PubMed: 21720365
    • Bell D, Berchuck A, Birrer M, Chien J, Cramer DW et al. (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615. doi:10.1038/nature10166. PubMed: 21720365.
    • (2011) Nature , vol.474 , pp. 609-615
    • Bell, D.1    Berchuck, A.2    Birrer, M.3    Chien, J.4    Cramer, D.W.5
  • 10
    • 77958484951 scopus 로고    scopus 로고
    • The genesis and evolution of high-grade serous ovarian cancer
    • doi:10.1038/nrc2946. PubMed: 20944665
    • Bowtell DD (2010) The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 10: 803-808. doi:10.1038/nrc2946. PubMed: 20944665.
    • (2010) Nat Rev Cancer , vol.10 , pp. 803-808
    • Bowtell, D.D.1
  • 11
    • 84867536072 scopus 로고    scopus 로고
    • Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome
    • doi: 10.1158/1078-0432.CCR-12-0857. PubMed: 22912389
    • Wang ZC, Birkbak NJ, Culhane AC, Drapkin R, Fatima A et al. (2012) Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome. Clin Cancer Res 18: 5806-5815. doi: 10.1158/1078-0432.CCR-12- 0857. PubMed: 22912389.
    • (2012) Clin Cancer Res , vol.18 , pp. 5806-5815
    • Wang, Z.C.1    Birkbak, N.J.2    Culhane, A.C.3    Drapkin, R.4    Fatima, A.5
  • 12
    • 84866261844 scopus 로고    scopus 로고
    • Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-Mutation damaging agents
    • doi: 10.1158/2159-8290.CD-11-0206 PubMed: 22576213
    • Birkbak NJ, Wang ZC, Kim JY, Eklund AC, Li Q et al. (2012) Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-Mutation damaging agents. Cancer Discov 2: 366-375. doi: 10.1158/2159-8290.CD-11-0206 PubMed: 22576213.
    • (2012) Cancer Discov , vol.2 , pp. 366-375
    • Birkbak, N.J.1    Wang, Z.C.2    Kim, J.Y.3    Eklund, A.C.4    Li, Q.5
  • 13
    • 77950974130 scopus 로고    scopus 로고
    • Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors
    • doi:10.1158/1078-0432.CCR-09-2758. PubMed: 20371688
    • Mukhopadhyay A, Elattar A, Cerbinskaite A, Wilkinson SJ, Drew Y et al. (2010) Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors. Clin Cancer Res 16: 2344-2351. doi:10.1158/1078-0432.CCR-09-2758. PubMed: 20371688.
    • (2010) Clin Cancer Res , vol.16 , pp. 2344-2351
    • Mukhopadhyay, A.1    Elattar, A.2    Cerbinskaite, A.3    Wilkinson, S.J.4    Drew, Y.5
  • 14
    • 84861550476 scopus 로고    scopus 로고
    • The life history of 21 breast cancers
    • doi: 10.1016/j.cell.2012.04.023. PubMed: 22608083
    • Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD et al. (2012) The life history of 21 breast cancers. Cell 149: 994-1007. doi: 10.1016/j.cell.2012.04.023. PubMed: 22608083.
    • (2012) Cell , vol.149 , pp. 994-1007
    • Nik-Zainal, S.1    Van Loo, P.2    Wedge, D.C.3    Alexandrov, L.B.4    Greenman, C.D.5
  • 15
    • 80053950209 scopus 로고    scopus 로고
    • Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer
    • doi:10.1001/jama.2011.1456. PubMed: 21990299
    • Yang D, Khan S, Sun Y, Hess K, Shmulevich I et al. (2011) Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA 306: 1557-1565. doi:10.1001/jama.2011.1456. PubMed: 21990299.
    • (2011) JAMA , vol.306 , pp. 1557-1565
    • Yang, D.1    Khan, S.2    Sun, Y.3    Hess, K.4    Shmulevich, I.5
  • 16
    • 84873441292 scopus 로고    scopus 로고
    • Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation
    • doi:10.1073/pnas.1221068110. PubMed: 23345422
    • Tomasetti C, Vogelstein B, Parmigiani G (2013) Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci U S A 110: 1999-2004. doi:10.1073/pnas. 1221068110. PubMed: 23345422.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , pp. 1999-2004
    • Tomasetti, C.1    Vogelstein, B.2    Parmigiani, G.3
  • 17
    • 84866256092 scopus 로고    scopus 로고
    • Mechanisms of BRCA1 tumor suppression
    • doi: 10.1158/2159-8290.CD-12-0221 PubMed: 22843421
    • Silver DP, Livingston DM (2012) Mechanisms of BRCA1 tumor suppression. Cancer Discov 2: 679-684. doi: 10.1158/2159-8290.CD-12-0221 PubMed: 22843421.
    • (2012) Cancer Discov , vol.2 , pp. 679-684
    • Silver, D.P.1    Livingston, D.M.2
  • 18
    • 82455218968 scopus 로고    scopus 로고
    • BRCA1 is required for postreplication repair after UV-induced DNA damage
    • doi:10.1016/j.molcel.2011.09.002. PubMed: 21963239
    • Pathania S, Nguyen J, Hill SJ, Scully R, Adelmant GO et al. (2011) BRCA1 is required for postreplication repair after UV-induced DNA damage. Mol Cell 44: 235-251. doi:10.1016/j.molcel.2011.09.002. PubMed: 21963239.
    • (2011) Mol Cell , vol.44 , pp. 235-251
    • Pathania, S.1    Nguyen, J.2    Hill, S.J.3    Scully, R.4    Adelmant, G.O.5
  • 19
    • 77951878399 scopus 로고    scopus 로고
    • Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass
    • doi:10.1038/onc.2010.18. PubMed: 20173781
    • Xie J, Litman R, Wang S, Peng M, Guillemette S et al. (2010) Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass. Oncogene 29: 2499-2508. doi:10.1038/onc.2010.18. PubMed: 20173781.
    • (2010) Oncogene , vol.29 , pp. 2499-2508
    • Xie, J.1    Litman, R.2    Wang, S.3    Peng, M.4    Guillemette, S.5
  • 20
    • 84882837534 scopus 로고    scopus 로고
    • Signatures of mutational processes in human cancer
    • doi:10.1038/nature12477. PubMed: 23945592
    • Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S et al. (2013) Signatures of mutational processes in human cancer. Nature 500: 415-421. doi:10.1038/nature12477. PubMed: 23945592.
    • (2013) Nature , vol.500 , pp. 415-421
    • Alexandrov, L.B.1    Nik-Zainal, S.2    Wedge, D.C.3    Aparicio, S.A.4    Behjati, S.5
  • 21
    • 79952746216 scopus 로고    scopus 로고
    • Secondary mutations of BRCA1/2 and drug resistance
    • doi:10.1111/j.1349-7006.2010.01840.x. PubMed: 21205087
    • Dhillon KK, Swisher EM, Taniguchi T (2011) Secondary mutations of BRCA1/2 and drug resistance. Cancer Sci 102: 663-669. doi:10.1111/j.1349-7006.2010. 01840.x. PubMed: 21205087.
    • (2011) Cancer Sci , vol.102 , pp. 663-669
    • Dhillon, K.K.1    Swisher, E.M.2    Taniguchi, T.3
  • 22
    • 4944229642 scopus 로고    scopus 로고
    • Hallmarks of 'BRCAness' in sporadic cancers
    • doi:10.1038/nrc1457. PubMed: 15510162
    • Turner N, Tutt A, Ashworth A (2004) Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer 4: 814-819. doi:10.1038/nrc1457. PubMed: 15510162.
    • (2004) Nat Rev Cancer , vol.4 , pp. 814-819
    • Turner, N.1    Tutt, A.2    Ashworth, A.3
  • 23
    • 77950958141 scopus 로고    scopus 로고
    • 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks
    • doi:10.1016/j.cell.2010.03.012. PubMed: 20362325
    • Bunting SF, Callén E, Wong N, Chen HT, Polato F et al. (2010) 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141: 243-254. doi:10.1016/j.cell.2010.03.012. PubMed: 20362325.
    • (2010) Cell , vol.141 , pp. 243-254
    • Bunting, S.F.1    Callén, E.2    Wong, N.3    Chen, H.T.4    Polato, F.5
  • 24
    • 84862776819 scopus 로고    scopus 로고
    • BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair
    • doi:10.1016/j.molcel.2012.02.015. PubMed: 22445484
    • Bunting SF, Callén E, Kozak ML, Kim JM, Wong N et al. (2012) BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell 46: 125-135. doi:10.1016/j.molcel.2012.02.015. PubMed: 22445484.
    • (2012) Mol Cell , vol.46 , pp. 125-135
    • Bunting, S.F.1    Callén, E.2    Kozak, M.L.3    Kim, J.M.4    Wong, N.5
  • 25
    • 39149118956 scopus 로고    scopus 로고
    • Optimal chemotherapy treatment for women with recurrent ovarian cancer
    • doi:10.3747/co.2007.148. PubMed: 17938703
    • Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, et al. (2007) Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol 14: 195-208. doi:10.3747/co.2007.148. PubMed: 17938703.
    • (2007) Curr Oncol , vol.14 , pp. 195-208
    • Fung-Kee-Fung, M.1    Oliver, T.2    Elit, L.3    Oza, A.4    Hirte, H.W.5
  • 26
    • 69949167276 scopus 로고    scopus 로고
    • A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6
    • doi:10.1093/bioinformatics/btp371. PubMed: 19535535
    • Bengtsson H, Wirapati P, Speed TP (2009) A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6. Bioinformatics 25: 2149-2156. doi:10.1093/bioinformatics/btp371. PubMed: 19535535.
    • (2009) Bioinformatics , vol.25 , pp. 2149-2156
    • Bengtsson, H.1    Wirapati, P.2    Speed, T.P.3
  • 27
    • 77951996044 scopus 로고    scopus 로고
    • TumorBoost: Normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays
    • doi: 10.1186/1471-2105-11-245. PubMed: 20462408
    • Bengtsson H, Neuvial P, Speed TP (2010) TumorBoost: normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays. BMC Bioinformatics 11: 245. doi: 10.1186/1471-2105-11-245. PubMed: 20462408.
    • (2010) BMC Bioinformatics , vol.11 , pp. 245
    • Bengtsson, H.1    Neuvial, P.2    Speed, T.P.3
  • 28
    • 84864023860 scopus 로고    scopus 로고
    • CalMaTe: A method and software to improve allele-specific copy number of SNP arrays for downstream segmentation
    • doi:10.1093/bioinformatics/bts248. PubMed: 22576175
    • Ortiz-Estevez M, Aramburu A, Bengtsson H, Neuvial P, Rubio A (2012) CalMaTe: a method and software to improve allele-specific copy number of SNP arrays for downstream segmentation. Bioinformatics 28: 1793-1794. doi:10.1093/bioinformatics/bts248. PubMed: 22576175.
    • (2012) Bioinformatics , vol.28 , pp. 1793-1794
    • Ortiz-Estevez, M.1    Aramburu, A.2    Bengtsson, H.3    Neuvial, P.4    Rubio, A.5
  • 29
    • 78049248432 scopus 로고    scopus 로고
    • Allele-specific copy number analysis of tumors
    • doi:10.1073/pnas.1009843107. PubMed: 20837533
    • Van Loo P, Nordgard SH, Lingjaerde OC, Russnes HG, Rye IH et al. (2010) Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 107: 16910-16915. doi:10.1073/pnas.1009843107. PubMed: 20837533.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 16910-16915
    • Van Loo, P.1    Nordgard, S.H.2    Lingjaerde, O.C.3    Russnes, H.G.4    Rye, I.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.